• Home
  • Investors
    • News Archive
    • Share Information
      • Shareholder Service
      • General Meetings
    • Reports
    • Board and Management
  • Contact

You are here

Home » Investors

News

Final results for 2005
Notice of ordinary general meeting
Mandatory notification of trade
Alloted share options
Genefec™ launched in Denmark
Results Q4 and preliminary results 2005
Presentation of Q4 and preliminary results 2005
Exclusive license and supply agreement
Minutes from extraordinary general meeting
Reimbursement of Genefec™ in Sweden
Summon to extraordinary general meeting
Oslo Børs - matching halt ends
Oslo Børs - matching halt
Genefec™ launched in Sweden
NorDiag – Subscription result share issue and publishing of subscription rate
Nordiag – The Board proposes share issue
NorDiag utvider avtale med Capio
Stor vekst for NorDiag ASA i tredje kvartal
Request for admission to stock exchange trading from NorDiag ASA
NorDiag AS licenses additional markers from Genzyme

Pages

  • « first
  • ‹ previous
  • …
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • next ›
  • last »
News archive

NORDA ASA  ♦  P.O. Box 1666 Vika  ♦   0110 Oslo  ♦   Norway  ♦   Phone: +47 92 42 35 61  ♦   web: www.nordasa.no